Research Opportunities The British Society for Rheumatology Biologics Register for Rheumatoid Arthritis (BSRBR-RA) is an observational cohort study, which has collected data on over 30,000 participants in the UK over more than two decades. This extensive dataset...
The BSRBR-RA regularly collaborates with patient support groups to guide the direction of their research. This involvement can take place through the ‘Registers and Research Committee’ at the British Society for Rheumatology, where lay members and patient groups are...
The BSRBR-RA is one of four biologics registers run by the British Society for Rheumatology: BSRBR-RA (University of Manchester) UK JIA Biologics Register (University of Manchester) Psoriatic Arthritis Register (University of Aberdeen) Ankylosing spondylitis...
The BSRBR-RA is fortunate to be able to collaborate with numerous different research groups both across the UK and internationally. As part of the JAK-pot collaboration, 19 registers internationally – including the British Society for Rheumatology Biologics Register...
Data from the BSRBR-RA study has influenced clinical guidelines.
The British Society for Rheumatology Biologics Register for Rheumatoid Arthritis (BSRBR-RA) study has been central in understanding the long-term safety and effectiveness of biologic, biosimilar and JAKi therapies for rheumatoid arthritis (RA). Over the past two...
Have you ever wondered where the data you provide are used?Whether you are a participant in the study, or an NHS professional who provides the data to BSRBR-RA, the answer is the same. This data is vital in the ongoing research into the long-term safety of biologic,...
2024 has been another great year for BSRBR-RA. We’re very grateful to the NHS professionals who provide data, and to the participants. The data provided is integral to the success of the research.Our year in numbersOur publications this year Association between body...
Dr Simon Tsoi investigated the association between body weight and tocilizumab effectiveness in rheumatoid arthritis, using data from the BSRBR-RA study. The results were published in the Rheumatology journal. What was already known?Tocilizumab is a type of treatment...
Read about some of the recent research from BSRBR-RA looking at JAK inhibitors. Bit of background about you Hello, my name is Zixing Tian, I am an epidemiologist with a research focus on rheumatoid arthritis (RA). I work on the BSRBR-RA study, where I recently...
+44 (0) 161 306 6000
Recent Comments